Kevin Kauffman

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index5.8kcitations82works11.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(30), Immune cells in cancer(25), Glycosylation and Glycoproteins Research(19), Advanced biosensing and bioanalysis techniques(16), Ubiquitin and proteasome pathways(14)

Publications82 total

Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types
International Journal of Molecular Sciences·2024· 11 citedOpen Access
1205 Surmounting conventional cell therapy limitations<i> via in situ</i> CAR therapy using oRNA™ lipid nanoparticles
Regular and Young Investigator Award Abstracts·2023Open Access
Supplementary Figure 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Supplementary Figure 4 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
FIGURE 6 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Supplementary Figure 4 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Data from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
FIGURE 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Data from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023· 1 citedOpen Access
Supplementary Figure 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Supplementary Figure 8 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
FIGURE 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
FIGURE 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Supplementary Figure 7 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Supplementary Table 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
FIGURE 6 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Supplementary Figure 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Supplementary Table 2 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
Supplementary Figure 7 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
FIGURE 5 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Daniel G. Anderson(26), Tatiana I. Novobrantseva(18), Mohammad Zafari(17), Ryan Phennicie(17), Igor Feldman(17), Denise Manfra(16), Dominika Nowakowska(16), Brian O’Nuallain(15), Veronica Komoroski(15), Michael A. Brehm(15), Phuong A. Nguyen(14), Michael W. Heartlein(13), Frank DeRosa(13), Elisabeth H. Vollmann(13), Sara Basinski(12), Kate Rooney(12), Elizabeth K. Culyba(12), Joseph Wahle(12), Carola H. Ries(12), Steve Sazinsky(12)